Capital World Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Capital World Investors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,443,000	Closed	-$35.9M	–	560
2019 Q4	$35.9M	Hold	3,443,000	–	–	0.01%	374
2019 Q3	$13.5M	Buy	3,443,000 +1,682,963	+96%	+$13.6M	﹤0.01%	448
2019 Q2	$26.2M	Buy	1,760,037 +1,227,037	+230%	+$22.2M	0.01%	408
2019 Q1	$13.2M	Hold	533,000	–	–	﹤0.01%	465
2018 Q4	$9.57M	Hold	533,000	–	–	﹤0.01%	474
2018 Q3	$15.7M	Sell	533,000 -119,000	-18%	-$4.61M	﹤0.01%	486
2018 Q2	$29.6M	Hold	652,000	–	–	0.01%	422
2018 Q1	$34.4M	Buy	+652,000	New	+$38M	0.01%	383

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Capital World Investors's CLVS Position: Q1 2020 in Review

Capital World Investors sold out of Clovis Oncology, Inc. (CLVS) in Q1 2020, closing a stake of 3,443,000 shares — an estimated $35.9M sold.

Capital World Investors first reported a position in CLVS in Q1 2018 and held it in 8 quarters. The position peaked at $35.9M in Q4 2019. 154 funds tracked by Wall St. Rank hold CLVS as of Q1 2020.

Capital World Investors reported no remaining Clovis Oncology, Inc. position as of Q1 2020 after selling out during the quarter.
Capital World Investors sold 3,443,000 Clovis Oncology, Inc. shares in Q1 2020, an estimated $35.9M.
Capital World Investors first reported a position in Clovis Oncology, Inc. in Q1 2018 and held it in 8 quarters.
Capital World Investors's Clovis Oncology, Inc. position peaked at $35.9M in Q4 2019.
154 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2020.

Based on Capital World Investors's 13F filing for Q1 2020, filed 15 May 2020.